Skip to main content

Table 16 PD patient distribution, by treatment for EPS and dialysis modality

From: Annual peritoneal dialysis report 2014, the peritoneal dialysis registry

Treatment for EPS EPS (−) EPS (+) Subtotal Unspecified No information available Total
Surgery (+) steroids (+) Surgery (+) steroids (−) Surgery (−) steroids (+) Surgery (−) steroids (−)
In-center HD (%) 5051 (91.2) 376 (6.8) 12 (0.2) 56 (1.0) 46 (0.8) 5541 (100.0) 198 730 6469
HDF (%) 1250 (90.5) 104 (7.5) 3 (0.2) 9 (0.7) 15 (1.1) 1381 (100.0) 35 161 1577
Hemofiltration (%) 1 (100.0) 1 (100.0) 1
Hemoadsorption (%) 46 (79.3) 8 (13.8) 1 (1.7) 3 (5.2) 58 (100.0) 4 3 65
Home HD (%) 72 (98.6) 1 (1.4) 73 (100.0) 4 77
PD (%) 5769 (99.3) 36 (0.6) 3 (0.1) 3 (0.1) 5811 (100.0) 67 3063 8941
Subtotal (%) 12,189 (94.7) 525 (4.1) 16 (0.1) 68 (0.5) 67 (0.5) 12,865 (100.0) 304 3961 17,130
No information available (%)
Total (%) 12,189 (94.7) 525 (4.2) 16 (0.2) 68 (0.6) 67 (0.4) 12,865 (100.0) 304 3961 17,130
  1. These data were obtained from the patients on PD and the patients with past PD history currently on another dialysis modality
  2. EPS encapsulating peritoneal sclerosis